Not applicableUnknownNCT02851329What this trial is testingTherapeutic Resistance Prediction of Tyrosine Kinase InhibitorsWho this might be right forNon-small Cell Lung Cancer Chinese Academy of Sciences 500
Not applicableEnded earlyNCT06015295What this trial is testingA Pilot Study to Assess the Clinical Utility of 18F-Fluciclovine (Axumin) PET-CT for Detecting True-versus Pseudo-Progression of Brain Metastases on ImmunotherapyWho this might be right forBrain Metastases M.D. Anderson Cancer Center 3
Not applicableUnknownNCT04273477What this trial is testingRadiomics-based Artificial Intelligence System to Predict Neoadjuvant Treatment Response in Rectal CancerWho this might be right forRectal Cancer Sixth Affiliated Hospital, Sun Yat-sen University 100
Not applicableUnknownNCT05807165What this trial is testingHF-SRT vs. HS-WBRT in Treating Patients With Brain OligometastasesWho this might be right forBrain Oligometastases Chang Gung Memorial Hospital 115
Not applicableNot Yet RecruitingNCT05184829What this trial is testingA Single-center Study on the Effect of Systemic/Selective Lymph Node Dissection on the Prognosis of Ground Glass Nodules Smaller Than 3cm and With Components With Consolidation/Tumor Ratio Between 0.5-1Who this might be right forProgressionPostoperative Recovery Shanghai Zhongshan Hospital 500
Testing effectiveness (Phase 2)Looking for participantsNCT06728865What this trial is testingEvaluation of the Efficacy and Safety of Furmonertinib Combined with Bevacizumab As First-Line Treatment for EGFR-Positive Non-Small Cell Lung Cancer with Brain Metastases: a Single-Arm, Open-Label, Prospective Phase II Clinical StudyWho this might be right forNon-small Cell Lung Cancer (NSCLC)EGFR Mutation-Positive Lung CancerBrain Metastases+2 more Li-kun Chen 70
Not applicableUnknownNCT04359745What this trial is testingImproving Treatment of Glioblastoma: Distinguishing Progression From PseudoprogressionWho this might be right forGlioblastoma Guy's and St Thomas' NHS Foundation Trust 500
Large-scale testing (Phase 3)Study completedNCT01168973What this trial is testingChemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based ChemotherapyWho this might be right forNon-Small Cell Lung Cancer Eli Lilly and Company 1,253
Testing effectiveness (Phase 2)Study completedNCT01251861What this trial is testingBicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate CancerWho this might be right forRecurrent Prostate CarcinomaStage I Prostate Cancer AJCC v7Stage IIA Prostate Cancer AJCC v7+2 more National Cancer Institute (NCI) 108
Testing effectiveness (Phase 2)Looking for participantsNCT05257018What this trial is testingR-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS RelapseWho this might be right forDiffuse Large B-cell Lymphoma Fudan University 83
Not applicableEnded earlyNCT01277120What this trial is testingAn Observational Study on The Correlation Between Time of Initiation of Avastin (Bevacizumab) Treatment And Progression-Free Survival in Patients With Colorectal Cancer (CRONOS 1)Who this might be right forColorectal Cancer Hoffmann-La Roche 174
Testing effectiveness (Phase 2)Study completedNCT02471313What this trial is testingIntegrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After ChemoembolizationWho this might be right forLiver CancerLiver NeoplasmHepatocellular Carcinoma+1 more National Institutes of Health Clinical Center (CC) 3
Large-scale testing (Phase 3)Ended earlyNCT00171925What this trial is testingTherapy With Zoledronic Acid in Patients With Multiple Myeloma Stage IWho this might be right forMultiple Myeloma Stage I Novartis Pharmaceuticals 143
Testing effectiveness (Phase 2)Study completedNCT00088946What this trial is testingErlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder CancerWho this might be right forBladder Cancer Jonsson Comprehensive Cancer Center 17
Testing effectiveness (Phase 2)Ended earlyNCT00538291What this trial is testingCetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan TreatmentWho this might be right forColorectal Cancer City of Hope Medical Center 13
Testing effectiveness (Phase 2)WithdrawnNCT01889680What this trial is testingSafety and Effectiveness Study of Chemotherapy and Ziv-aflibercept to Treat Metastatic Colorectal CancerWho this might be right forColorectal CancerMetastatic Colorectal Cancer NSABP Foundation Inc
Not applicableStudy completedNCT02751138What this trial is testingDetermination of Immune Phenotype in Glioblastoma PatientsWho this might be right forGlioblastoma Multiforme University of Ulm 100
Large-scale testing (Phase 3)Study completedNCT00808743What this trial is testingPrevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous PolyposisWho this might be right forFamilial Adenomatous PolyposisDuodenal NeoplasmsDuodenal Polyps Radboud University Medical Center 37
Not applicableStudy completedNCT02392078What this trial is testingLaser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate SystemWho this might be right forMetastatic Brain TumorPrimary Brain TumorEpileptic/Seizure Foci+1 more Monteris Medical 1,153
Not applicableStudy completedNCT03721289What this trial is testingEvaluation in Real World of Molecular Testing and Treatment Patterns for EGFR Mutation in Lung Cancer PatientsWho this might be right forCarcinoma, Non-Small-Cell Lung AstraZeneca 463